🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This protocol will evaluate the efficacy and safety of various combinations...
Status
Completed
Location
Bhaluka UZHC
Start Date
2010-05
Trial ID
NCT01122771
The overall objective of this trial is to identify a safe and effective com...
Status
Completed
Location
Kala-azar medical centre
Start Date
2008-06
Trial ID
NCT00696969
Rationale The overall objective of this trial is to identify a safe and ef...
Status
Completed
Location
Kala-azar Medical Research Center
Start Date
2007-09
Trial ID
NCT00523965
The overall objective of this trial is to identify a safe and effective tre...
Status
Completed
Location
MSF
Start Date
2014-07
Trial ID
NCT02011958
Treatments Being Tested
The investigators are using a sequential design to combine miltefosine and ...
Status
Completed
Location
Kala-azar Medical Research Center
Start Date
2006-09
Trial ID
NCT00370825
Treatments Being Tested
MAMS4CL comprises a clinical trial with three embedded sub-studies designed...
Status
Not Yet Recruiting
Location
ALERT Hospital
Start Date
2027-01-01
Trial ID
NCT07463040
Miltefosine and liposomal amphotericin B (AmBisome) are approved drugs for ...
Status
Completed
Location
Kala-azar Medical Research Center
Start Date
2007-10
Trial ID
NCT00371995
Treatments Being Tested
Randomised clinical trial comparing oral miltefosine associated with pentox...
Status
Unknown
Location
Hospital Universitario de Brasilia
Start Date
2022-06-22
Trial ID
NCT06040489
Treatments Being Tested
The cell behavior that the investigators regard as "malignant," including: ...
Status
Unknown
Location
Dr. Frank Arguello Cancer Clinic
Start Date
2011-07-26
Trial ID
NCT02366884
Treatments Being Tested
The purpose of this protocol is to conduct a randomized comparison of the e...
Status
Unknown
Location
Hospital Dermatologico de Jorochito
Start Date
2021-04-01
Trial ID
NCT04799236
Treatments Being Tested